Arvinas, Inc. (ARVN) — 10-K Filings

All 10-K filings from Arvinas, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

  • Arvinas Files 2024 Annual Report — Feb 11, 2025 Risk: medium
    Arvinas, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company is a biopharmaceutical company focused on developing orally bioav
  • Arvinas, Inc. Files 2023 Annual Report on Form 10-K — Feb 27, 2024 Risk: medium
    ARVINAS, INC. (ARVN) filed a Annual Report (10-K) with the SEC on February 27, 2024. Arvinas, Inc. reported its 2023 fiscal year results on February 27, 2024. T

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.